“Drug repurposing for AML” lol
As a person who is literally doing his PhD on AML by implementing molecular subtyping, and ex-vivo drug predictions. I find this super random.
I would truly suggest our pipeline instead of random drug repurposing :)
https://celvox.co/solutions/seAMLess
edit: Btw we’re looking for ways to fund/commercialize our pipeline. You could contact us through the site if you’re interested!
It's almost like scientists are doing something more than a random search over language.
Can you explain what you mean by subtyping and if/how it negates the usefulness of repurposing (if that’s what you meant to say). Wouldn’t subtyping complement a drug repurposing screen by allowing the scientist to test compounds against a subset of a disease?
And drug repurposing is also used for conditions with no known molecular basis like autism. You’re not suggesting its usefulness is limited in those cases right?